N@N

GOODO, MELA, OPTR, TSON, ADY, FARM Are Seasonally Ripe To Go Down In the Next Five Weeks

^{Published on 2012-10-16 07:43:12 - WOPRAI}
 

October 16, 2012 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Gladstone Commercial Corp (NASDAQ:GOODO), MELA Sciences Inc (NASDAQ:MELA), Optimer Pharmaceuticals Inc (NASDAQ:OPTR), TranS1 Inc (NASDAQ:TSON), Feihe International Inc (NYSE:ADY), Farmer Bros Co (NASDAQ:FARM) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at: http://www.squeezetrigger.com/services/strat/mh.php

The following stocks are expected to go Down:

  Symbol  Company                          Expected Return  Odds                 By The Following Date
  GOODO   Gladstone Commercial Corp        -1.79%           100.00% (5 of 5)     Monday, October 22nd 2012
  MELA    MELA Sciences Inc                -18.78%          66.67% (4 of 6)      Monday, November 12th 2012
  OPTR    Optimer Pharmaceuticals Inc      -7.38%           100.00% (5 of 5)     Monday, November 5th 2012
  TSON    TranS1 Inc                       -27.68%          100.00% (5 of 5)     Wednesday, November 28th 2012
  ADY     Feihe International Inc          -6.36%           100.00% (8 of 8)     Friday, October 19th 2012
  FARM    Farmer Bros Co                   -2.70%           91.67% (11 of 12)    Friday, October 19th 2012

MELA Sciences Inc (NASDAQ:MELA) - MELA Sciences, Inc. operates as a medical device company that focuses on the design and development of a non-invasive, point-of-care instrument to assist in the early diagnosis of melanoma. The companys principal product, MelaFind, features a hand-held imaging device that emits multiple wavelengths of light to capture images of suspicious pigmented skin lesions and extract data. This product uses automatic image analysis and statistical pattern recognition to help identify lesions to be considered for biopsy to rule out melanoma. It consists of hand-held imaging device, which employs high precision optics and multi-spectral illumination; database of pigmented skin lesions; and lesion classifiers, which are mathematical algorithms that extract lesion feature information and classify lesions. MELA Sciences filed the MelaFind pre-market approval application with the U.S. Food and Drug Administration (FDA) in June 2009 and is under review at the FDA. The company was formerly known as Electro-Optical Sciences, Inc. and changed its name MELA Sciences, Inc. in April 2010. MELA Sciences was founded in 1989 and is based in Irvington, New York..

Optimer Pharmaceuticals Inc (NASDAQ:OPTR) - Optimer Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing anti-infective products worldwide. It develops products that treat gastrointestinal infections and related diseases. The companys two late-stage anti-infective product candidates include Fidaxomicin, the lead product candidate and an antibiotic for the treatment of clostridium difficile-infections, which completed two Phase III clinical trial; and Prulifloxacin, a prodrug in the fluoroquinolone class of antibiotics, which completed two Phase III trials for the treatment of infectious diarrhea, including travelers diarrhea. It also develops product candidates using its proprietary technology Optimer One-Pot Synthesis, a drug discovery platform and a computer-aided technology that enables the synthesis of carbohydrate-based compounds. In addition, the companys other pipeline product candidates consist of CEM-101 (OP-1068), a macrolide and ketolide antibiotic for the treatment of upper and lower respiratory tract infections; OPT-88, a disease-modifying intra-articular therapy for osteoarthritis; and OPT-822/OPT-821, a carbohydrate-based immunostimulant therapy for the treatment of metastatic breast cancer. Additionally, it licensed rights to Cempra Pharmaceuticals, Inc. to develop CEM-101; and granted rights to Optimer Biopharmaceuticals, Inc. to develop OPT-88 and OPT-822/821. Further, the company has collaborative agreements with Par Pharmaceuticals, Inc.; Nippon Shinyaku, Co., Ltd.; Memorial Sloan-Kettering Cancer Center; and Scripps Research Institute. Optimer Pharmaceuticals was founded in 1998 and is based in San Diego, California..

TranS1 Inc (NASDAQ:TSON) - TranS1 Inc., a medical device company, focuses on the design, development, and marketing of products that implement its proprietary surgical approach to treat degenerative disc disease and instability affecting the lower lumbar region of the spine. The company offers TranS1 pre-sacral approach that enables spine surgeons to access and treat degenerative lumbar discs, as well as to perform fusion and motion preserving surgeries in the L4/L5/S1 region. Its products include AxiaLIF lumbar fusion implant, a threaded titanium rod to enable one-level L5/S1 fusions and two-level L4/L5/S1 fusions; AxiaLIF 360 implants, which consist of 3D Axial Rod plus its titanium facet screws for supplemental posterior fixation; and TranS1 access and disc preparation instruments. In addition, the company, through a partnership agreement with Life Spine, Inc., distributes Avatar, a minimally invasive pedicle screw system. It markets and sells its products through direct sales representatives and independent sales agents in the United States, as well as primarily through third-party distributors in Europe. The company was formerly known as aXiaMed, Inc. and changed its name to TranS1 Inc. in February 2003. TranS1 Inc. was founded in 2000 and is headquartered in Wilmington, North Carolina..

Feihe International Inc (NYSE:ADY) - Feihe International, Inc. engages in the production and distribution of infant formula, milk powder, soybean, rice cereal, and walnut products in the People's Republic of China. The company also offers cream, skim milk powder, full milk powder, butter, cheese, and other related milk powder products, as well as markets and distributes water and cheese for children. Its products are formulated for various ages, dietary needs, and health concerns, including infants and young children, expectant mothers, students, and the middle-aged and elderly populations. The company also process and distributes semi-finished milk powder to beverage manufacturers and other wholesalers for use in their blended drink products. As of October 13, 2010, it operated approximately 200 company-owned milk collection stations; 2 dairy farms; 7 production facilities with an aggregate milk powder production capacity of approximately 1,250 tons per day; and a distribution network that reaches approximately 95,000 retail outlets. The company was formerly known as American Dairy, Inc. and changed its name to Feihe International, Inc. on October 13, 2010. Feihe International, Inc. was founded in 1962 and is headquartered in Beijing, the Peoples Republic of China..

Farmer Bros Co (NASDAQ:FARM) - Farmer Bros. Co., together with its subsidiaries, engages in the manufacture, wholesale, and distribution of coffee, tea, and culinary products in the United States. Its product line includes roasted coffee; liquid coffee; and coffee related products, such as coffee filters, sugar and creamers, assorted teas, cappuccino, cocoa, spices, gelatins and puddings, soup, gravy and sauce mixes, pancake and biscuit mixes, and jellies and preserves. The company offers its products to small restaurants, donut shops, restaurant chains, hotels, casinos, hospitals, food service providers, and convenience stores, as well as gourmet coffee houses, private-label retailers, mass market merchandisers, other national accounts, and grocery stores. Farmer Bros. distributes its products through direct and brokered sales. The company was founded in 1912 and is headquartered in Torrance, California..

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com

www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.

INVESTMENTS & TRADING

SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

About SQUEEZETRIGGER.COM

WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641